Company Filing History:
1 out of 4 
1 out of 4 
1 out of 154 
Years Active: 2017
Title: The Innovations of Jean-Michel Coindre
Introduction
Jean-Michel Coindre is a notable inventor based in Bordeaux, France. He has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of soft tissue sarcomas. His work has implications for improving patient outcomes and advancing medical science.
Latest Patents
Jean-Michel Coindre holds a patent titled "Prognostic molecular signature of sarcomas, and uses thereof." This patent describes methods and compositions that can be utilized for the diagnosis and treatment of soft tissue sarcoma cancer phenotypes and associated diseases. Additionally, it outlines methods for identifying modulators of soft tissue sarcoma cancer, showcasing his innovative approach to tackling complex medical challenges.
Career Highlights
Throughout his career, Coindre has been affiliated with prestigious institutions such as Université Bordeaux Segalen and Institut Bergonié. His work at these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Coindre has worked alongside notable colleagues, including Frédéric Chibon and Alain Aurias. Their combined expertise has furthered the understanding of sarcomas and enhanced the development of effective treatment strategies.
Conclusion
Jean-Michel Coindre's contributions to cancer research, particularly through his patent on soft tissue sarcomas, highlight his role as an innovative inventor in the medical field. His work continues to influence the diagnosis and treatment of cancer, paving the way for future advancements.